Autoimmune CAR T Safety Events Reshape Rheumatologist Sentiment, but Autologous CAR T Retains Lead, According to Spherix Global Insights
Longitudinal analysis finds safety concerns surge following recent trial pauses, while systemic sclerosis remains the clearest near-term opportunity for immune reset therapy. Longitudinal analysis finds safety concerns surge following recent trial pauses, while systemic sclerosis remains the clearest near-term opportun…
Short extract only — this publisher licenses its text. Read the full release at the source.
More from Commercial newswire
- SCTE TechExpo26 Showcases the Technology Powering the Connected Future
- Global Orphan Project's GOEX Marks One Year of Its Haiti Factory Opening, Celebrating the Workers Behind Every Shirt
- From Personal Injury Lawyer to Digital Brand: Amanda Demanda to Share Meta Advertising Strategies at PIMCon
The rest of this wire is for subscribers
Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
7 days, no card required.
Read releases like this the second they cross the wire.
1,400+ feeds — live on PPN World right now. Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
Start the free trial →Your announcement next? Distribute your press release to the global wires with PPN Source — and track its pickup live here.
PPN Source →